GPR64, Screened from Ewing Sarcoma Cells, Is a Potential Target for Antibody-Based Therapy for Various Sarcomas

SIMPLE SUMMARY: New strategies for immunotherapy have led to an increased interest in tumor-specific antigens on the cell surface in the field of oncology. Identifying markers in sarcomas is difficult because their tumor mutation burden is less than that of carcinomas. We assumed that a target prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Koichi, Asanuma, Kunihiro, Okamoto, Takayuki, Yoshida, Keisuke, Matsuyama, Yumi, Kita, Kouji, Hagi, Tomohito, Nakamura, Tomoki, Sudo, Akihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834492/
https://www.ncbi.nlm.nih.gov/pubmed/35159080
http://dx.doi.org/10.3390/cancers14030814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834492/
https://www.ncbi.nlm.nih.gov/pubmed/35159080
http://dx.doi.org/10.3390/cancers14030814

Ejemplares similares